Ivan Kairatov is a Biopharma expert with deep knowledge of technology and innovation in the industry, with experience in research and development. Today, we discuss the recent FDA approval of adaptive deep brain stimulation (aDBS) as a new treatment option for Parkinson’s disease. Can you explain
The transformative role of artificial intelligence (AI) and deep learning (DL) in the realm of medical imaging is ushering in a new era for the diagnosis and prognosis of oral potentially malignant disorders (OPMDs). These technologies are spearheading advancements in early detection and risk
In this interview, we are pleased to welcome Ivan Kairatov, a Biopharma expert with deep knowledge of tech and innovation in the industry and extensive experience in research and development, particularly in gene therapy for sensory disorders. Today, Ivan will share insights on the recent positive
Ivan Kairatov is a biopharma expert with extensive knowledge of technology and innovation in the industry. He has significant experience in research and development and is here to discuss recent findings about lung abnormalities in children and adolescents with long COVID. What is long COVID, and
Colorectal cancer (CRC) remains one of the leading causes of cancer-related deaths worldwide, primarily due to its high potential for metastasis and the related challenges in treatment. These challenges often include drug toxicity, tumor recurrence, and development of drug resistance due to genetic
Ivan Kairatov is a Biopharma expert, with profound knowledge in technology and innovation in the medical industry, and extensive experience in research and development. Today, we'll delve into a study from the University of Colorado Anschutz Medical Campus, discussing its significance for diabetes
